Concepedia

Author

Melissa Krauth

The University of Texas Southwestern Medical Center

Also Known As

M. C. Krauth, M. Krauth, Melissa Krauth

10

Publications

2.3K

Citations

9

H-Index

28

Concepts

All Affiliations

The University of Texas Southwestern Medical CenterReata Pharmaceuticals (United States)Statistics CollaborativeUniversity of Alabama at BirminghamRenal Associates P. A.
MK

About

Melissa Krauth is an author at The University of Texas Southwestern Medical Center specializing in medicine, pharmacology, and metabolic syndrome.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

309

2

Health Sciences

2

2

66

3

Diabetes

2

2

243

4

Biochemistry

1

1

13

5

Biomolecular Engineering

1

1

13

Melissa Krauth

×

9

Publications

2.3K

Citations

9

H-Index

YearCitations

Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease

Dick de Zeeuw, Tadao Akizawa, Paul Audhya,

New England Journal of Medicine

2013

969

Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes

Pablo E. Pérgola, Philip Raskin, Robert D. Toto,

New England Journal of Medicine

2011

868

Effect of Bardoxolone Methyl on Kidney Function in Patients with T2D and Stage 3b–4 CKD

Pablo E. Pérgola, Melissa Krauth, Jesse W. Huff,

American Journal of Nephrology

2011

230

Rationale and Trial Design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: The Occurrence of Renal Events (BEACON)

Dick de Zeeuw, Tadao Akizawa, Rajiv Agarwal,

American Journal of Nephrology

2013

91

Late breaking clinical trials 1

C. G. M. Kallenberg, Ulrich Specks, John H. Stone,

Clinical Kidney Journal

2011

53

Peloruside A Inhibits Growth of Human Lung and Breast Tumor Xenografts in an Athymic <i>nu</i>/<i>nu</i> Mouse Model

Colin J. Meyer, Melissa Krauth, Michael J. Wick,

Molecular Cancer Therapeutics

2015

25

Baseline characteristics in the Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes mellitus: the Occurrence of renal eveNts (BEACON) trial

Hiddo J.L. Heerspink, Glenn M. Chertow, Tadao Akizawa,

Nephrology Dialysis Transplantation

2013

20

639 POSTER RTA 301 (peloruside): a novel microtubule stabilizer with potent in vivo activity against lung cancer and resistant breast cancer

Craig S. Meyer, David Ferguson, Melissa Krauth,

European Journal of Cancer Supplements

2006

13

CHANGES IN INSULIN RECEPTOR CONCENTRATION IN RAT FAT CELLS FOLLOWING TREATMENT WITH THE GESTAGENS CLOMEGESTONE ACETATE AND CYPROTERONE ACETATE

Melissa Krauth, E. Schillinger

European Journal of Endocrinology

1977

13

Page 1